Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study.

Lamprea-Montealegre JA, Zelnick LR, Shlipak MG, Floyd JS, Anderson AH, He J, Christenson R, Seliger SL, Soliman EZ, Deo R, Ky B, Feldman HI, Kusek JW, deFilippi CR, Wolf MS, Shafi T, Go AS, Bansal N; CRIC Study Investigators.

J Am Heart Assoc. 2019 Aug 6;8(15):e012200. doi: 10.1161/JAHA.119.012200. Epub 2019 Aug 5.

2.

Physician Judgment and Circulating Biomarkers Predict 28-Day Mortality in Emergency Department Patients.

Henning DJ, Bhatraju PK, Johnson NJ, Kosamo S, Shapiro NI, Zelnick LR, Liles WC, Wurfel MM.

Crit Care Med. 2019 Aug 1. doi: 10.1097/CCM.0000000000003899. [Epub ahead of print]

PMID:
31369425
3.

Differences in proximal tubular solute clearance across common etiologies of chronic kidney disease.

Wang K, Zelnick LR, Hoofnagle AN, Chen Y, de Boer IH, Himmelfarb J, Kestenbaum B.

Nephrol Dial Transplant. 2019 Jul 25. pii: gfz144. doi: 10.1093/ndt/gfz144. [Epub ahead of print]

PMID:
31347660
4.

Two-phase, generalized case-control designs for quantitative longitudinal outcomes.

Schildcrout JS, Haneuse S, Tao R, Zelnick LR, Schisterman EF, Garbett SP, Mercaldo ND, Rathouz PJ, Heagerty PJ.

Am J Epidemiol. 2019 Jun 5. pii: kwz127. doi: 10.1093/aje/kwz127. [Epub ahead of print]

PMID:
31165875
5.

Albuminuria, the High-Density Lipoprotein Proteome, and Coronary Artery Calcification in Type 1 Diabetes Mellitus.

Shao B, Zelnick LR, Wimberger J, Himmelfarb J, Brunzell J, Davidson WS, Snell-Bergeon JK, Bornfeldt KE, de Boer IH, Heinecke JW.

Arterioscler Thromb Vasc Biol. 2019 Jul;39(7):1483-1491. doi: 10.1161/ATVBAHA.119.312556. Epub 2019 May 16.

PMID:
31092010
6.

Mineral Metabolism Disturbances and Arteriovenous Fistula Maturation.

Kubiak RW, Zelnick LR, Hoofnagle AN, Alpers CE, Terry CM, Shiu YT, Cheung AK, de Boer IH, Robinson-Cohen C, Allon M, Dember LM, Feldman HI, Himmelfarb J, Huber TS, Roy-Chaudhury P, Vazquez MA, Kusek JW, Beck GJ, Imrey PB, Kestenbaum B; Hemodialysis Fistula Maturation Study Group.

Eur J Vasc Endovasc Surg. 2019 May;57(5):719-728. doi: 10.1016/j.ejvs.2019.01.022. Epub 2019 Apr 15.

PMID:
31000459
7.

Hypoglycemia in People with Type 2 Diabetes and CKD.

Ahmad I, Zelnick LR, Batacchi Z, Robinson N, Dighe A, Manski-Nankervis JE, Furler J, O'Neal DN, Little R, Trence D, Hirsch IB, Bansal N, de Boer IH.

Clin J Am Soc Nephrol. 2019 Jun 7;14(6):844-853. doi: 10.2215/CJN.11650918. Epub 2019 Apr 17.

PMID:
30996047
8.

A Prediction Model for Severe AKI in Critically Ill Adults That Incorporates Clinical and Biomarker Data.

Bhatraju PK, Zelnick LR, Katz R, Mikacenic C, Kosamo S, Hahn WO, Dmyterko V, Kestenbaum B, Christiani DC, Liles WC, Himmelfarb J, Wurfel MM.

Clin J Am Soc Nephrol. 2019 Apr 5;14(4):506-514. doi: 10.2215/CJN.04100318. Epub 2019 Mar 27.

PMID:
30917991
9.

Rates of Cardiac Rhythm Abnormalities in Patients with CKD and Diabetes.

Akoum N, Zelnick LR, de Boer IH, Hirsch IB, Trence D, Henry C, Robinson N, Bansal N.

Clin J Am Soc Nephrol. 2019 Apr 5;14(4):549-556. doi: 10.2215/CJN.09420818. Epub 2019 Mar 19.

PMID:
30890578
10.

Gene Expression Studies and Targeted Metabolomics Reveal Disturbed Serine, Methionine, and Tyrosine Metabolism in Early Hypertensive Nephrosclerosis.

Øvrehus MA, Bruheim P, Ju W, Zelnick LR, Langlo KA, Sharma K, de Boer IH, Hallan SI.

Kidney Int Rep. 2018 Oct 17;4(2):321-333. doi: 10.1016/j.ekir.2018.10.007. eCollection 2019 Feb.

11.

Prevalence of Hypertension and Cardiovascular Risk According to Blood Pressure Thresholds Used for Diagnosis.

Lamprea-Montealegre JA, Zelnick LR, Hall YN, Bansal N, de Boer IH.

Hypertension. 2018 Sep;72(3):602-609. doi: 10.1161/HYPERTENSIONAHA.118.11609.

PMID:
30354757
12.

Identification of Acute Kidney Injury Subphenotypes with Differing Molecular Signatures and Responses to Vasopressin Therapy.

Bhatraju PK, Zelnick LR, Herting J, Katz R, Mikacenic C, Kosamo S, Morrell ED, Robinson-Cohen C, Calfee CS, Christie JD, Liu KD, Matthay MA, Hahn WO, Dmyterko V, Slivinski NSJ, Russell JA, Walley KR, Christiani DC, Liles WC, Himmelfarb J, Wurfel MM.

Am J Respir Crit Care Med. 2019 Apr 1;199(7):863-872. doi: 10.1164/rccm.201807-1346OC.

PMID:
30334632
13.

Association of Soluble TNFR-1 Concentrations with Long-Term Decline in Kidney Function: The Multi-Ethnic Study of Atherosclerosis.

Bhatraju PK, Zelnick LR, Shlipak M, Katz R, Kestenbaum B.

J Am Soc Nephrol. 2018 Nov;29(11):2713-2721. doi: 10.1681/ASN.2018070719. Epub 2018 Oct 4.

PMID:
30287518
14.

Vitamin D and omega-3 trial to prevent and treat diabetic kidney disease: Rationale, design, and baseline characteristics.

de Boer IH, Zelnick LR, Lin J, Schaumberg D, Wang L, Ruzinski J, Friedenberg G, Duszlak J, Bubes VY, Hoofnagle AN, Thadhani R, Glynn RJ, Buring JE, Sesso HD, Manson JE.

Contemp Clin Trials. 2018 Nov;74:11-17. doi: 10.1016/j.cct.2018.09.014. Epub 2018 Sep 30.

PMID:
30282055
15.

Chronic kidney disease attenuates the plasma metabolome response to insulin.

Roshanravan B, Zelnick LR, Djucovic D, Gu H, Alvarez JA, Ziegler TR, Gamboa JL, Utzschneider K, Kestenbaum B, Himmelfarb J, Kahn SE, Raftery D, de Boer IH.

JCI Insight. 2018 Aug 23;3(16). pii: 122219. doi: 10.1172/jci.insight.122219. eCollection 2018 Aug 23.

16.

Effect of Anti-Hypertensive Medication History on Arteriovenous Fistula Maturation Outcomes.

Wang K, Zelnick LR, Imrey PB, deBoer IH, Himmelfarb J, Allon MD, Cheung AK, Dember LM, Roy-Chaudhury P, Vazquez MA, Kusek JW, Feldman HI, Beck GJ, Kestenbaum B; the Hemodialysis Fistula Maturation Study Group.

Am J Nephrol. 2018;48(1):56-64. doi: 10.1159/000491828. Epub 2018 Aug 2.

17.

Alteration of HDL Protein Composition with Hemodialysis Initiation.

Wang K, Zelnick LR, Hoofnagle AN, Vaisar T, Henderson CM, Imrey PB, Robinson-Cohen C, de Boer IH, Shiu YT, Himmelfarb J, Beck GJ, Kestenbaum B; HFM Study.

Clin J Am Soc Nephrol. 2018 Aug 7;13(8):1225-1233. doi: 10.2215/CJN.11321017. Epub 2018 Jul 25.

18.

Bioelectrical Impedance Analysis Measures and Clinical Outcomes in CKD.

Bansal N, Zelnick LR, Himmelfarb J, Chertow GM.

Am J Kidney Dis. 2018 Nov;72(5):662-672. doi: 10.1053/j.ajkd.2018.03.030. Epub 2018 Jun 6.

PMID:
29885923
19.

Likelihood-based analysis of outcome-dependent sampling designs with longitudinal data.

Zelnick LR, Schildcrout JS, Heagerty PJ.

Stat Med. 2018 Jun 15;37(13):2120-2133. doi: 10.1002/sim.7633. Epub 2018 Mar 15.

20.

Comparative Effects of Cholecalciferol and Calcitriol on Circulating Markers of CKD Mineral Bone Disorder: A Randomized Clinical Trial.

Zelnick LR, de Boer IH, Kestenbaum BR, Chonchol M, Kendrick J.

Clin J Am Soc Nephrol. 2018 Jun 7;13(6):927-928. doi: 10.2215/CJN.00480118. Epub 2018 Mar 7. No abstract available.

21.

Metabolomics and Gene Expression Analysis Reveal Down-regulation of the Citric Acid (TCA) Cycle in Non-diabetic CKD Patients.

Hallan S, Afkarian M, Zelnick LR, Kestenbaum B, Sharma S, Saito R, Darshi M, Barding G, Raftery D, Ju W, Kretzler M, Sharma K, de Boer IH.

EBioMedicine. 2017 Dec;26:68-77. doi: 10.1016/j.ebiom.2017.10.027. Epub 2017 Oct 31.

22.

Diabetes and CKD in the United States Population, 2009-2014.

Zelnick LR, Weiss NS, Kestenbaum BR, Robinson-Cohen C, Heagerty PJ, Tuttle K, Hall YN, Hirsch IB, de Boer IH.

Clin J Am Soc Nephrol. 2017 Dec 7;12(12):1984-1990. doi: 10.2215/CJN.03700417. Epub 2017 Oct 20.

23.

eGFR and Albuminuria in Relation to Risk of Incident Atrial Fibrillation: A Meta-Analysis of the Jackson Heart Study, the Multi-Ethnic Study of Atherosclerosis, and the Cardiovascular Health Study.

Bansal N, Zelnick LR, Alonso A, Benjamin EJ, de Boer IH, Deo R, Katz R, Kestenbaum B, Mathew J, Robinson-Cohen C, Sarnak MJ, Shlipak MG, Sotoodehnia N, Young B, Heckbert SR.

Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1386-1398. doi: 10.2215/CJN.01860217. Epub 2017 Aug 10.

24.

Associations of Vitamin D-Binding Globulin and Bioavailable Vitamin D Concentrations With Coronary Heart Disease Events: The Multi-Ethnic Study of Atherosclerosis (MESA).

Robinson-Cohen C, Zelnick LR, Hoofnagle AN, Lutsey PL, Burke G, Michos ED, Shea SJC, Tracy R, Siscovick DS, Psaty B, Kestenbaum B, de Boer IH.

J Clin Endocrinol Metab. 2017 Aug 1;102(8):3075-3084. doi: 10.1210/jc.2017-00296.

25.

Diurnal and Long-term Variation in Plasma Concentrations and Renal Clearances of Circulating Markers of Kidney Proximal Tubular Secretion.

Rivara MB, Zelnick LR, Hoofnagle AN, Newitt R, Tracy RP, Kratz M, Weigle DS, Kestenbaum BR.

Clin Chem. 2017 Apr;63(4):915-923. doi: 10.1373/clinchem.2016.260117. Epub 2017 Feb 10.

26.

Echocardiographic Measures and Estimated GFR Decline Among African Americans: The Jackson Heart Study.

Zelnick LR, Katz R, Young BA, Correa A, Kestenbaum BR, de Boer IH, Bansal N.

Am J Kidney Dis. 2017 Aug;70(2):199-206. doi: 10.1053/j.ajkd.2016.11.022. Epub 2017 Jan 28.

27.

Chronic kidney disease and obesity bias surrogate estimates of insulin sensitivity compared with the hyperinsulinemic euglycemic clamp.

Ahmad I, Zelnick LR, Robinson NR, Hung AM, Kestenbaum B, Utzschneider KM, Kahn SE, de Boer IH.

Am J Physiol Endocrinol Metab. 2017 Mar 1;312(3):E175-E182. doi: 10.1152/ajpendo.00394.2016. Epub 2017 Jan 10.

28.

Physical activity and metabolic health in chronic kidney disease: a cross-sectional study.

Bowlby W, Zelnick LR, Henry C, Himmelfarb J, Kahn SE, Kestenbaum B, Robinson-Cohen C, Utzschneider KM, de Boer IH.

BMC Nephrol. 2016 Nov 22;17(1):187.

29.

Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014.

Afkarian M, Zelnick LR, Hall YN, Heagerty PJ, Tuttle K, Weiss NS, de Boer IH.

JAMA. 2016 Aug 9;316(6):602-10. doi: 10.1001/jama.2016.10924.

30.

Urine matrix metalloproteinase-7 and risk of kidney disease progression and mortality in type 2 diabetes.

Afkarian M, Zelnick LR, Ruzinski J, Kestenbaum B, Himmelfarb J, de Boer IH, Mehrotra R.

J Diabetes Complications. 2015 Nov-Dec;29(8):1024-31. doi: 10.1016/j.jdiacomp.2015.08.024. Epub 2015 Sep 2.

31.

BIASED SAMPLING DESIGNS TO IMPROVE RESEARCH EFFICIENCY: FACTORS INFLUENCING PULMONARY FUNCTION OVER TIME IN CHILDREN WITH ASTHMA.

Schildcrout JS, Rathouz PJ, Zelnick LR, Garbett SP, Heagerty PJ.

Ann Appl Stat. 2015 Jun;9(2):731-753.

32.

Addressing the challenges of obtaining functional outcomes in traumatic brain injury research: missing data patterns, timing of follow-up, and three prognostic models.

Zelnick LR, Morrison LJ, Devlin SM, Bulger EM, Brasel KJ, Sheehan K, Minei JP, Kerby JD, Tisherman SA, Rizoli S, Karmy-Jones R, van Heest R, Newgard CD; Resuscitation Outcomes Consortium Investigators.

J Neurotrauma. 2014 Jun 1;31(11):1029-38. doi: 10.1089/neu.2013.3122. Epub 2014 May 8.

33.

Detectable clonal mosaicism from birth to old age and its relationship to cancer.

Laurie CC, Laurie CA, Rice K, Doheny KF, Zelnick LR, McHugh CP, Ling H, Hetrick KN, Pugh EW, Amos C, Wei Q, Wang LE, Lee JE, Barnes KC, Hansel NN, Mathias R, Daley D, Beaty TH, Scott AF, Ruczinski I, Scharpf RB, Bierut LJ, Hartz SM, Landi MT, Freedman ND, Goldin LR, Ginsburg D, Li J, Desch KC, Strom SS, Blot WJ, Signorello LB, Ingles SA, Chanock SJ, Berndt SI, Le Marchand L, Henderson BE, Monroe KR, Heit JA, de Andrade M, Armasu SM, Regnier C, Lowe WL, Hayes MG, Marazita ML, Feingold E, Murray JC, Melbye M, Feenstra B, Kang JH, Wiggs JL, Jarvik GP, McDavid AN, Seshan VE, Mirel DB, Crenshaw A, Sharopova N, Wise A, Shen J, Crosslin DR, Levine DM, Zheng X, Udren JI, Bennett S, Nelson SC, Gogarten SM, Conomos MP, Heagerty P, Manolio T, Pasquale LR, Haiman CA, Caporaso N, Weir BS.

Nat Genet. 2012 May 6;44(6):642-50. doi: 10.1038/ng.2271.

Supplemental Content

Loading ...
Support Center